Prosecution Insights
Prosecution Insights
23 pending office actions • 17 art units • 21 examiners • 0 of 23 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (13%) |
| §103 only | 8 (35%) |
| §102 only | 1 (4%) |
| §112 only | 1 (4%) |
| Double-patenting only | 1 (4%) |
| Multi-statute (no §101) | 7 (30%) |
| No statute on record | 2 (9%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, TAEYOON | 2 | 51.6% | +51.8% |
| WANG, RUIXUE | 2 | 57.4% | +22.1% |
| BRUTUS, JOEL F | 1 | 72.6% | +17.9% |
| DIBRINO, MARIANNE | 1 | 43.2% | +41.6% |
| SHERMAN, ERIC SCOTT | 1 | 72.3% | +16.6% |
| MACHNESS, ARIELLA | 1 | 61.3% | +28.6% |
| SCHUBERG, LAURA J | 1 | 23.7% | +37.2% |
| ALFANO, ALAN | 1 | — | — |
| STOICA, ELLY GERALD | 1 | 66.8% | +22.7% |
| DABKOWSKI, ERINNE R | 1 | 55.8% | +69.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17780961 | BIOMASS-BASED SOLID COMPOSITE ELECTROLYTES FOR BATTERIES | NGUYEN, KEVIN NMN | 56d overdue |
| 17641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | MEJIAS, SAMANTHA LEE | 3d overdue |
| 18014919 | SULFIDE COMPOSITE ELECTROLYTES FOR SOLID-STATE LITHIUM BATTERIES | ORLANDO, MICHAEL N | 2d overdue |
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 12d |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 20d |
| 17757599 | VIRUS-LIKE PARTICLE BINDING AGENTS, RELATED COMPOSITIONS, AND RELATED METHODS | JADHAO, SAMADHAN JAISING | 22d |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 34d |
| 19265967 | COMPUTER-AIDED SYSTEM AND METHOD FOR DETERMINATION OF AUTISM SPECTRUM DISORDER SEVERITY BY ASSESSMENT MODULE | BRUTUS, JOEL F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 12d |
| 18030174 | GRIFFITHSIN FOR RHABDOVIRIDAE INFECTIONS | DABKOWSKI, ERINNE R | 14d |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 20d |
| 18233416 | IN-PROCESS ULTRASONIC POLLING OF 3D PRINTED CRYSTALLINE/SEMICRYSTALLINE ELECTROACTIVE POLYMERS | MACHNESS, ARIELLA | 29d |
| 18124656 | HUMAN FACILITATING CELLS | KIM, TAEYOON | 29d |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 34d |
| 19265967 | COMPUTER-AIDED SYSTEM AND METHOD FOR DETERMINATION OF AUTISM SPECTRUM DISORDER SEVERITY BY ASSESSMENT MODULE | BRUTUS, JOEL F | — |
| 18277684 | Actinohivin Variant Polypeptides and Related Methods | DIBRINO, MARIANNE | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1672 | 3 |
| 1641 | 2 |
| 1618 | 2 |
| 3797 | 1 |
| 1736 | 1 |
| 1743 | 1 |
| 1647 | 1 |
| 1654 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19265967 | COMPUTER-AIDED SYSTEM AND METHOD FOR DETERMINATION OF AUTISM SPECTRUM DISORDER SEVERITY BY ASSESSMENT MODULE | BRUTUS, JOEL F | 3797 | §101§102§103 | Non-Final OA | — | Pending | Jul 10, 2025 |
| 18277684 | Actinohivin Variant Polypeptides and Related Methods | DIBRINO, MARIANNE | 1641 | DP | Final Rejection | — | Pending | Aug 17, 2023 |
| 18450060 | ULTRATHIN NANORIBBONS OF HIGHLY ANISOTROPIC LAYERED MATERIAL AND METHOD OF PRODUCTION | SHERMAN, ERIC SCOTT | 1736 | §102 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18233416 | IN-PROCESS ULTRASONIC POLLING OF 3D PRINTED CRYSTALLINE/SEMICRYSTALLINE ELECTROACTIVE POLYMERS | MACHNESS, ARIELLA | 1743 | §103 | Final Rejection | 29d | Pending | Aug 14, 2023 |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | 34d | Pending | Aug 04, 2023 |
| 18261950 | ACTINOHIVIN VARIANT POLYPEPTIDES AND RELATED METHODS | ALFANO, ALAN | 1641 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18333400 | METHOD OF INHIBITING LUNG OR BREAST CANCER GROWTH WITH ENGINEERED EMBRYONIC STEM-CELL DERIVED EXOSOMES COMPOSITIONS | STOICA, ELLY GERALD | 1647 | §103 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18030174 | GRIFFITHSIN FOR RHABDOVIRIDAE INFECTIONS | DABKOWSKI, ERINNE R | 1654 | §103 | Final Rejection | 14d | Pending | Apr 04, 2023 |
| 18124656 | HUMAN FACILITATING CELLS | KIM, TAEYOON | 1631 | Other | Final Rejection | 29d | Pending | Mar 22, 2023 |
| 18162777 | CELL LINES, SYSTEMS, KITS, AND METHODS FOR DETERMINING THE SPECIFICITY AND/OR POTENCY OF CERAMIDASE INHIBITORS | TICHY, JENNIFER M.H. | 1637 | §103 | Non-Final OA | — | Pending | Feb 01, 2023 |
| 18014919 | SULFIDE COMPOSITE ELECTROLYTES FOR SOLID-STATE LITHIUM BATTERIES | ORLANDO, MICHAEL N | 1746 | §103§112 | Final Rejection | 2d overdue | Pending | Jan 06, 2023 |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 1672 | §101§102§112 | Non-Final OA | 20d | Pending | Dec 05, 2022 |
| 17997764 | BIOMIMETIC HEART TISSUE CULTURE SYSTEM | HENKEL, DANIELLE B | 1799 | §103§112 | Non-Final OA | — | Pending | Nov 02, 2022 |
| 17913575 | METHODS AND COMPOSITIONS FOR DETECTING VIRUSES | WANG, RUIXUE | 1672 | §103 | Final Rejection | — | Pending | Sep 22, 2022 |
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 1631 | §103§112Other | Final Rejection | 12d | Pending | Jul 12, 2022 |
| 17757599 | VIRUS-LIKE PARTICLE BINDING AGENTS, RELATED COMPOSITIONS, AND RELATED METHODS | JADHAO, SAMADHAN JAISING | 1672 | §102§103§112 | Non-Final OA | 22d | Pending | Jun 17, 2022 |
| 17780961 | BIOMASS-BASED SOLID COMPOSITE ELECTROLYTES FOR BATTERIES | NGUYEN, KEVIN NMN | 1752 | §103§112 | Non-Final OA | 56d overdue | Pending | May 27, 2022 |
| 17741686 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES | JONES, DAMERON LEVEST | 1618 | §102§112Other | Final Rejection | — | Pending | May 11, 2022 |
| 17641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | MEJIAS, SAMANTHA LEE | 1618 | §102§103§112Other | Final Rejection | 3d overdue | Pending | Mar 09, 2022 |
| 17629309 | IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USING | HILL, MYRON G | 1671 | §112 | Final Rejection | — | Pending | Jan 21, 2022 |
| 17291495 | METHODS AND COMPOSITION FOR TREATING MICROBIAL INFECTIONS | HINES, JANA A | 1645 | §103 | Final Rejection | — | Pending | May 05, 2021 |
| 17230280 | METHODS FOR PROVIDING OPTIMIZED NEUROSTIMULATION | FAIRCHILD, MALLIKA DIPAYAN | 3792 | Other | Final Rejection | 5d overdue | Pending | Apr 14, 2021 |
| 16789572 | MODULAR HARNESS FOR PATIENTS WITH POST-NEUROLOGIC INJURY | MILLER, CHRISTOPHER E | 3785 | §103 | Non-Final OA | — | Pending | Feb 13, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial